DISTINCT study
HIP-ATTACK-II study, Hip-Attack 2 study, Hip fracture, elevated Troponin

Title:  ‘The DISTINCT trial: inDividual, targeted thrombosIS prophylaxis versus the standard 'one size fits all' approach in patients undergoing Total hIp or total kNee replaCemenT: a national, multicenter, randomized, multi-arm, open-la-bel trial' 


Principal investigator: Prof. Dr. R.W. Poolman
Contact:xxxxxxxxxxxxE. Scheijbeler & L.A.C. Roubos


Initiating centre:xixixiLUMC

The inclusion phase is ongoing. Patients who are on the waiting list for a total hip or knee replacement may be eligible to participate.